79209645 - CRESCENDO BIOLOGICS

Information

• Trademark
• 79209645

• Source

• Serial Number

  79209645

• Registration Number

  5488713

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 40 - Treatment of materials

• Filing Date

  October 21, 2016
  8 years ago

• Registration Date

  June 12, 2018
  6 years ago

• Transaction Date

  December 05, 2024
  a month ago

• Status Date

  June 12, 2018
  6 years ago

• Published for Opposition Date

  March 27, 2018
  6 years ago

• Location Date

  June 12, 2018
  6 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  LEE, JEANIE

• Attorney Docket Number

  17337.26USIB

  Attorney Name

  Christopher J. Schulte

  Law Office Assigned Location Code

  L50

• Owners

  • CRESCENDO BIOLOGICS LTD

Case File Statements

• GS0401: Treatment and transformation of materials for others, namely the custom manufacture of chemicals, biologicals, antibodies and antibody fragments; contract manufacturing services in the field of chemicals, biologicals, antibodies and antibody fragments; services for the custom manufacture of medical therapies using antibodies and antibody fragments
• DM0000: The mark consists of a design of three circles each having U-shaped cut-outs. The three circles are centered above the stylized wording "Crescendo" directly above the stylised wording "biologics".
• GS0051: Pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases; veterinary preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases; therapeutic preparations in the nature of antibodies and antibody fragments for medical and veterinary purposes, namely, therapeutic pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases; antibodies, being pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases; antibody fragments, being pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases; monoclonal antibody therapies for therapeutic purposes, being pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases; antibodies and antibody fragments, being pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases, for medical and veterinary diagnostics; antibodies and antibody fragments, being pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases, for use in the discovery, preclinical and clinical development of therapeutic products; antibodies and antibody fragments, being pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases, for use in the manufacture of therapeutic products
• CC0000: Color is not claimed as a feature of the mark.
• GS0011: Chemicals used in industry and science; chemicals for laboratory research purposes, namely, chemical tests kits for in vitro testing; antibodies and antibody fragments for scientific and laboratory use in the nature of biochemical, namely, monoclonal antibodies for in vitro scientific or research use; biochemical, namely, monoclonal antibodies and antibody fragments for scientific and laboratory use; antibodies and antibody fragments all being protein in raw material form for scientific research purposes; antibody reagents used for the detection of antigens in cell and tissue analysis for scientific and laboratory in vitro diagnostic use; antibodies and antibody fragments all being proteins for industrial use in the discovery, preclinical and clinical development of therapeutic products
• DS0000: "BIOLOGICS"

Case File Event Statements

• 6/8/2017 - 7 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 6/12/2017 - 7 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 6/12/2017 - 7 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 6/14/2017 - 7 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 6/15/2017 - 7 years ago

  5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 6/16/2017 - 7 years ago

  6 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 6/23/2017 - 7 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 6/23/2017 - 7 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 7/14/2017 - 7 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 12/7/2017 - 7 years ago

  10 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 12/19/2017 - 7 years ago

  11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 12/19/2017 - 7 years ago

  12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/20/2017 - 7 years ago

  13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 1/11/2018 - 7 years ago

  14 - FINAL REFUSAL WRITTEN Type: CNFR

• 1/12/2018 - 7 years ago

  15 - FINAL REFUSAL MAILED Type: CNFR

• 2/1/2018 - 6 years ago

  16 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 2/1/2018 - 6 years ago

  17 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 2/14/2018 - 6 years ago

  18 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR

• 2/14/2018 - 6 years ago

  19 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 2/14/2018 - 6 years ago

  20 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 2/16/2018 - 6 years ago

  21 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 3/7/2018 - 6 years ago

  22 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 3/7/2018 - 6 years ago

  23 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 3/7/2018 - 6 years ago

  24 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 3/24/2018 - 6 years ago

  25 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 3/27/2018 - 6 years ago

  26 - PUBLISHED FOR OPPOSITION Type: PUBO

• 3/27/2018 - 6 years ago

  27 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 6/12/2018 - 6 years ago

  28 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 9/12/2018 - 6 years ago

  29 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 9/18/2018 - 6 years ago

  30 - FINAL DISPOSITION PROCESSED Type: FIMP

• 9/18/2018 - 6 years ago

  31 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 10/6/2018 - 6 years ago

  32 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 6/12/2023 - a year ago

  33 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3

• 8/19/2023 - a year ago

  34 - RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED Type: RHRD

• 10/27/2023 - a year ago

  35 - LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED Type: LIMN

• 11/8/2024 - 2 months ago

  36 - RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED Type: RHRD

• 12/4/2024 - a month ago

  37 - TEAS SECTION 71 RECEIVED Type: ES71